JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB106350

Anti-IL-8 抗体

Anti-IL-8 antibody

Be the first to review this product! Submit a review

|

(27 Publications)

Rabbit Polyclonal IL-8 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 27 publications. Immunogen corresponding to Synthetic Peptide within Human CXCL8 aa 50 to C-terminus.

別名を表示する

IL8, CXCL8, Interleukin-8, IL-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, Emoctakin, Granulocyte chemotactic protein 1, Monocyte-derived neutrophil chemotactic factor, Monocyte-derived neutrophil-activating peptide, Neutrophil-activating protein 1, Protein 3-10C, T-cell chemotactic factor, GCP-1, MDNCF, MONAP, NAP-1

4 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-8 antibody (AB106350)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-8 antibody (AB106350)

IL8 was detected in a paraffin-embedded section of human stomach cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 μg/ml ab106350 overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using a HRP conjugated Rabbit IgG with DAB as the chromogen.

Western blot - Anti-IL-8 antibody (AB106350)
  • WB

Supplier Data

Western blot - Anti-IL-8 antibody (AB106350)

Blocking and diluting buffer and concentration : 5% NFDM/TBST.

In Western blot, ab322732 and ab106350 were shown to bind specifically to IL-8. Target of interest was observed at 11 kDa in untreated wild-type PC-3 cell lysates (lane 1) and upregulated in treated wild-type PC-3 cell lysates (lane 2). No signal was observed at this size in untreated IL-8 knockout cell line (lane 3) or treated IL-8 knockout cell line (lane 4).

Recombinant multiclonal ab322732 showed higher sensitivity than polyclonal ab106350.

In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.

All lanes:

Western blot - Anti-IL-8 antibody [RM1267] (<a href='/products/primary-antibodies/il-8-antibody-rm1267-ab322732'>ab322732</a>) at 1/1000 dilution

Lane 1:

Untreated Wild-type PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

Wild-type PC-3 treated with2 ug/ml LPS for 1 hour, 5ug/ml Brefeldin A was then added for additional 5 hours, whole cell lysate at 20 µg

Lane 3:

Untreated CXCL8 knockout PC-3 whole cell lysate at 20 µg

Lane 4:

CXCL8 knockout PC-3 treated with 2 ug/ml LPS for 1 hour, 5ug/ml Brefeldin A was then added for additional 5 hours, whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Observed band size: 11 kDa,36 kDa

false

Exposure time: 180s

Western blot - Anti-IL-8 antibody (AB106350)
  • WB

Supplier Data

Western blot - Anti-IL-8 antibody (AB106350)

All lanes:

Western blot - Anti-IL-8 antibody (ab106350) at 0.5 µg/mL

All lanes:

Recombinant human IL8 protein at 10 ng

Secondary

All lanes:

Goat anti-rabbit IgG-HRP at 1/5000 dilution

false

Western blot - Anti-IL-8 antibody (AB106350)
  • WB

CiteAb

Western blot - Anti-IL-8 antibody (AB106350)

Western Blotting using Anti-IL-8 antibody, ab106350. Publication image from Allouch, A. et al., 2022, Nat Commun, 36347876. Legend direct from paper.

Tumor cell phagocytosis triggers the proinflammatory activation of macrophages.a Schematic representation of the coculture of CMFDA-labeled MDMs with CMTMR-labeled malignant hematologic cells. b Confocal micrograph of MDMs and Jurkat cells after 8 h of coculture. c, d Percentage of phagocytosis of leukemia cells or PBLs (c) or CD34+ AML cells (d) in control (Co.)- or ZVAD (100 µM)-treated cocultures. e FACS dot plot of Phago+ MDMs or Phago- MDMs sorted after 2 h of coculture with MOLT4 cells. f, g Confocal micrographs and percentages of CMTMR+CMFDA+ MDMs at 2 h (**p = 0.0079) (f, g) and 96 h (h, i) after Phago+ MDMs and Phago- MDMs sorting. j–n Phago+ MDMs were analyzed in comparison to Phago- MDMs to characterize modulated genes by a microarray (**p = 0.0022, *p = 0.0152) (j), CD163 membrane expression by FACS (**p = 0.0039) (k), and IRF5 expression by western blot (WB) analysis (l) and the supernatant (SN) was evaluated for indicated proinflammatory cytokines by WB analysis (l) or for IFNγ by a cytokine microarray (*p = 0.0286) (m) or ELISA (***p = 0.0008) (n) at 96 h (j, k, m) and 7 d (l, n) after FACS sorting. o, p Transwell coculture model of Phago+ MDMs and Phago- MDMs at 2 h after FACS sorting (o), and iNOS expression identified by WB analysis of Phago- MDMs cocultured in the bottom chambers for 15 d (p). In b, l, p and e, f, h, the data are representative of n = 3 and n = 5 donors. In c, n, d, and g, i, the data are presented as the mean±SEM from n = 3, n = 6, and n = 5 donors. In d, the CD34+ cells were from n = 4 AML patients. In j, box plots show centre line as median, box limits as upper and lower quartiles, and whiskers as a minimum to maximum values, from n = 3 donors. In k and m, the data are donor matched from n = 9 and n = 4 donors. Exact p-values are indicated and determined with two- (g) or one-tailed (m) unpaired Mann-Whitney test, the Kolmogorov–Smirnov test (j), a two-tailed paired Wilcoxon test (k), and a two-tailed unpaired t test (n). Source data are provided as a Source Data file.

false

Key facts

宿主種

Rabbit

クローン性

Polyclonal

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

WB, IHC-P

applications

免疫原

Synthetic Peptide within Human CXCL8 aa 50 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P10145

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "2-5 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-0.5 µg/mL", "WB-species-notes": "<p></p>" } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Immunogen
バッファー組成
Constituents: 76.92% Trehalose, 17.31% Sodium chloride, 3.85% Disodium hydrogenorthophosphate
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

IL-8 also known as CXCL8 is a cytokine with a molecular weight of approximately 8 kDa. It belongs to the CXC chemokine family and plays a role in the recruitment of neutrophils to sites of inflammation. Cells like monocytes macrophages and endothelial cells express IL-8 after activation by pro-inflammatory signals. The protein exhibits high expression in cells associated with the immune response and inflammation serving as a signaling molecule between these cell types.
Biological function summary

IL-8 functions as a chemoattractant for neutrophils and lymphocytes facilitating their movement towards the site of infection or injury. It does not form part of a larger protein complex but operates individually to enhance immune cell migration. IL-8 possesses unique binding motifs allowing it to interact with specific receptors namely CXCR1 and CXCR2 on target cells. This binding triggers cellular responses leading to effective immune surveillance and response to inflammatory stimuli.

Pathways

IL-8 operates within important inflammatory and immune response pathways. It forms a part of the NF-κB signaling cascade which activates in response to stress signals promoting the expression of other inflammatory mediators. Additionally it engages in the mitogen-activated protein kinase (MAPK) pathway influencing cellular responses such as proliferation and differentiation. The interaction of IL-8 with these pathways highlights its role in modulating immune responses and highlights its interaction with other proteins such as TNF-α and IL-1β.

IL-8 shows a strong association with conditions like rheumatoid arthritis and chronic obstructive pulmonary disease (COPD). It acts as a biomarker for these diseases often correlating with disease severity and inflammation levels. In rheumatoid arthritis IL-8 contributes to joint inflammation and degradation while in COPD it enhances airway inflammation and tissue damage. The cytokine's involvement in these diseases connects it with other inflammatory mediators such as MMPs and leukotrienes which collectively exacerbate disease pathology.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Chemotactic factor that mediates inflammatory response by attracting neutrophils, basophils, and T-cells to clear pathogens and protect the host from infection (PubMed : 18692776, PubMed : 7636208). Also plays an important role in neutrophil activation (PubMed : 2145175, PubMed : 9623510). Released in response to an inflammatory stimulus, exerts its effect by binding to the G-protein-coupled receptors CXCR1 and CXCR2, primarily found in neutrophils, monocytes and endothelial cells (PubMed : 1840701, PubMed : 1891716). G-protein heterotrimer (alpha, beta, gamma subunits) constitutively binds to CXCR1/CXCR2 receptor and activation by IL8 leads to beta and gamma subunits release from Galpha (GNAI2 in neutrophils) and activation of several downstream signaling pathways including PI3K and MAPK pathways (PubMed : 11971003, PubMed : 8662698).
See full target information CXCL8

文献 (27)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:4128 PubMed40319089

2025

Harnessing the FGFR2/NF2/YAP signaling-dependent necroptosis to develop an FGFR2/IL-8 dual blockade therapeutic strategy.

Applications

Unspecified application

Species

Unspecified reactive species

Dongshao Chen,Zitong Zhao,Ruoxi Hong,Di Yang,Ying Gong,Qingnan Wu,Yan Wang,Yiren Cao,Jie Chen,Yidi Tai,Haoyu Liu,Jinting Li,Jiawen Fan,Weimin Zhang,Yongmei Song,Qimin Zhan

Cancer immunology, immunotherapy : CII 74:47 PubMed39751958

2025

Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Wu,Guohui Qin,Jinyan Liu,Qitai Zhao,Xueke Zhao,Xin Song,Lidong Wang,Shengli Yang,Yi Zhang

Cells 13: PubMed39451241

2024

Activation of Mammary Epithelial and Stromal Fibroblasts upon Exposure to Metabolites.

Applications

Unspecified application

Species

Unspecified reactive species

Jamilah H Alshehri,Huda K Al-Nasrallah,Mysoon M Al-Ansari,Abdelilah Aboussekhra

Stem cell reviews and reports 20:1954-1970 PubMed39028417

2024

Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction.

Applications

Unspecified application

Species

Unspecified reactive species

Georgia P Wong,Sunhild Hartmann,David G Simmons,Sarah Ellis,Olivia Nonn,Ping Cannon,Tuong-Vi Nguyen,Anna Nguyen,Lucy A Bartho,Stephen Tong,Natalie J Hannan,Tu'uhevaha J Kaitu'u-Lino

Heliyon 9:e17315 PubMed37539258

2023

Extracts from Wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells.

Applications

Unspecified application

Species

Unspecified reactive species

Mengmeng Wang,Xunqing Yin,Yongcheng Zeng,Chunyan Hu,Yongmei Xue,Qionglian Fang,Xue Qiao,Xiujuan Zhao,Chenghong Du,Feng Huang,Yuping Lin

JCI insight 8: PubMed37192004

2023

JP1 normalizes tumor vasculature to suppress metastasis and facilitate drug delivery by inhibiting IL-8.

Applications

Unspecified application

Species

Unspecified reactive species

Jiahua Cui,Zhen Che,Lu Zou,Dongyin Chen,Zhan Xie,Kun Ding,Huning Jiang,Aiping Li,Jianwei Zhou,Yongqian Shu

The Journal of dermatology 50:1150-1155 PubMed37288510

2023

Three cases of subcorneal pustular dermatosis with immunohistochemical examinations.

Applications

Unspecified application

Species

Unspecified reactive species

Megumi Kishimoto,Mayumi Komine,Hirofumi Okada,Atsuko Sato,Koji Kamiya,Takeo Maekawa,Satoru Murata,Mamitaro Ohtsuki

Nature communications 13:6739 PubMed36347876

2022

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Awatef Allouch,Laurent Voisin,Yanyan Zhang,Syed Qasim Raza,Yann Lecluse,Julien Calvo,Dorothée Selimoglu-Buet,Stéphane de Botton,Fawzia Louache,Françoise Pflumio,Eric Solary,Jean-Luc Perfettini

Pathology, research and practice 238:154076 PubMed36055087

2022

WDR5 drives the development of cervical squamous cell carcinoma by inducing epithelial-mesenchymal transition and cancer-associated fibroblasts formation.

Applications

Unspecified application

Species

Unspecified reactive species

Fangli Sun,Linmei Mo,Ying Lan,Qiuping Lu,Nengxian Wu,Honglin Song

Cell death discovery 8:235 PubMed35487914

2022

Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Huning Jiang,Jiahua Cui,Hao Chu,Tingting Xu,Mengyan Xie,Xinming Jing,Jiali Xu,Jianwei Zhou,Yongqian Shu
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com